stop tirzepatide cold turkey Should You Wean Off Zepbound? Discontinuation Guide The Dangers Of Quitting Opiates

WARNING THIS PRODUCT IS ONLY IN

Mounjaro is an FDA-approved brand-name tirzepatide originally indicated for type 2 diabetes, with dual GLP-1 and GIP receptor action that has shown significant weight loss results in clinical trials.

Compared to semaglutide alone, the combination resulted in significantly greater weight loss, better body composition, and reductions in visceral fat and inflammation

Novo Nordisk and Eurofarma have launched programs to expand access to medications before entry of competitors as patents expire

This session will focus on the convergence of food and pharma, which joins a sister trend in health/care: food-as-medicine